Literature DB >> 25530451

NADH-linked metabolic plasticity of MCF-7 breast cancer cells surviving in a nutrient-deprived microenvironment.

Angela M Otto1, Josef Hintermair, Cornelia Janzon.   

Abstract

Characteristic of the tumor microenvironment are fluctuating gradients of reduced nutrient levels and released lactate. A fundamental issue is how tumor cells modulate their metabolic activity when both glucose and glutamine levels become limiting in the presence of high exogenous lactate. For functional analyses, the activities of pyruvate kinase, lactate dehydrogenase (LDH) and plasma membrane NADH oxidase (NOX) as well as cell growth were measured in breast cancer MCF-7 cells cultured in medium containing various concentrations of these metabolites. After 3 days at glucose concentrations below 2.5 mM, cell number was higher with 0.1 mM than with 1.0 mM glutamine, indicating that the glucose/glutamine balance is important for growth. On the other hand, NOX activity increased with increasing glucose >2.5 mM, but only with low glutamine (0.1 mM). Pyruvate kinase activity also increased, with LDH activity remaining 2-3-fold lower. Here NOX could have a complementary role in reoxidizing NADH for glycolysis. Exogenous lactate supported cell survival at limiting concentrations of glucose and glutamine while increasing NOX and pyruvate kinase activities as well as NADH levels. It is proposed that lactate supports cell survival by fuelling gluconeogenesis and/or the TCA cycle in mitochondria, from where NADH could be shuttled to the cytosol and reoxidized by NOX. Cell survival and the metabolic phenotype are thus interrelated to the dynamics of NADH and plasma membrane NOX activity, which are regulated by the balance of glucose/glutamine levels, in conjunction with lactate in a precarious tumor microenvironment.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  GLUCOSE; GLUTAMINE; GLYCOLYTIC ENZYMES; LACTATE; NUTRIENT DEPRIVATION; PLASMA MEMBRANE NADH OXIDASE; TUMOR METABOLISM

Mesh:

Substances:

Year:  2015        PMID: 25530451     DOI: 10.1002/jcb.25038

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  8 in total

Review 1.  Harnessing cancer cell metabolism for theranostic applications using metabolic glycoengineering of sialic acid in breast cancer as a pioneering example.

Authors:  Haitham A Badr; Dina M M AlSadek; Motawa E El-Houseini; Christopher T Saeui; Mohit P Mathew; Kevin J Yarema; Hafiz Ahmed
Journal:  Biomaterials       Date:  2016-11-25       Impact factor: 12.479

2.  Galectin-3 Targeting in Thyroid Orthotopic Tumors Opens New Ways to Characterize Thyroid Cancer.

Authors:  Francesco De Rose; Miriam Braeuer; Sten Braesch-Andersen; Angela M Otto; Katja Steiger; Sybille Reder; Sabine Mall; Stephan Nekolla; Markus Schwaiger; Wolfgang A Weber; Armando Bartolazzi; Calogero D'Alessandria
Journal:  J Nucl Med       Date:  2018-10-25       Impact factor: 10.057

Review 3.  Lactate shuttle: from substance exchange to regulatory mechanism.

Authors:  Xingchen Wang; He Liu; Yingqian Ni; Peibo Shen; Xiuzhen Han
Journal:  Hum Cell       Date:  2021-10-04       Impact factor: 4.174

4.  Glycolysis, tumor metabolism, cancer growth and dissemination. A new pH-based etiopathogenic perspective and therapeutic approach to an old cancer question.

Authors:  Khalid O Alfarouk; Daniel Verduzco; Cyril Rauch; Abdel Khalig Muddathir; H H Bashir Adil; Gamal O Elhassan; Muntaser E Ibrahim; Julian David Polo Orozco; Rosa Angela Cardone; Stephan J Reshkin; Salvador Harguindey
Journal:  Oncoscience       Date:  2014-12-18

5.  Conversion of Hyperpolarized [1-13C]Pyruvate in Breast Cancer Cells Depends on Their Malignancy, Metabolic Program and Nutrient Microenvironment.

Authors:  Martin Grashei; Philipp Biechl; Franz Schilling; Angela M Otto
Journal:  Cancers (Basel)       Date:  2022-04-06       Impact factor: 6.639

Review 6.  Mitochondrial Flexibility of Breast Cancers: A Growth Advantage and a Therapeutic Opportunity.

Authors:  Angelica Avagliano; Maria Rosaria Ruocco; Federica Aliotta; Immacolata Belviso; Antonello Accurso; Stefania Masone; Stefania Montagnani; Alessandro Arcucci
Journal:  Cells       Date:  2019-04-30       Impact factor: 6.600

7.  Diverse Roads Taken by 13C-Glucose-Derived Metabolites in Breast Cancer Cells Exposed to Limiting Glucose and Glutamine Conditions.

Authors:  Maria Gkiouli; Philipp Biechl; Wolfgang Eisenreich; Angela M Otto
Journal:  Cells       Date:  2019-09-20       Impact factor: 6.600

8.  Extracellular NAD+ enhances PARP-dependent DNA repair capacity independently of CD73 activity.

Authors:  Anna Wilk; Faisal Hayat; Richard Cunningham; Jianfeng Li; Silvia Garavaglia; Leila Zamani; Davide M Ferraris; Peter Sykora; Joel Andrews; Jennifer Clark; Amanda Davis; Laurent Chaloin; Menico Rizzi; Marie Migaud; Robert W Sobol
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.